×

This site uses own and third-party cookies to offer a better service. If you continue browsing we will consider you accepting its use.

Consortium

9 PARTNERS FROM 5 MEMBER STATES

5 REASEARCH GROUPS:

  • 1.- IK4-CIDETEC (Spain)
  • 2.- Université de Bordeaux (France)
  • 3.- Universidad del País Vasco/Euskal Herriko Unibertsitatea (Spain)
  • 5.- Université Claude Bernard Lyon I (France)
  • 8.- Istituto di Ricerche Farmacologiche Mario Negri (Italy)

2 SMEs:

  • 4.- Ahava - Dead Sea Laboratories LTD (Israel)
  • 6.- Polypeptide Therapeutic Soluitons SL (Spain)

2 CONSULTING AGENCIES:

  • 7.- Angel Consulting (Italy)
  • 9.- Spinverse (Finland)

PeptiCaps consortium consists 9 partners from 4 Member States and Israel. 5 research organization or universities with scientific and engineer background, namely IK4-CIDETEC, Université de Bordeaux, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Université Claude Bernard Lyon I and Istituto di Ricerche Farmacologiche Mario Negri will work in close collaboration with 2 SMEs, Polypeptide Therapeutic Solutions SL and AHAVA – Dead Sea Laboratories LTD, in order to facilitate the translation of PeptiCaps technology to the market. This translation will be guided by the recommendations of 2 consulting agencies expert in business plan and cosmetics products: Spinverse and Angel Consulting, respectively. Each partner has a significant and complementary track record in knowledge creation and innovation in their respective domains of expertise to guarantee the success of PeptiCaps project.